Consultations
We consult on proposed changes to the way we regulate medicines, medical devices and biologicals. Additional consultations about changes to the Poisons Standard can be found in the Scheduling decisions (interim) section of our publications hub.
Filter results
You can narrow down the results using the filters
Topic
- Scheduling (national classification system) (68)
- Medical devices (62)
- Therapeutic goods regulation (13)
- Over the counter medicine (12)
- Prescription medicines (10)
- Complementary medicines (8)
- Medicines (8)
- Advisory bodies and committees (7)
- Legislation (6)
- Manufacturing (5)
- Biologicals (4)
- Labelling and packaging (4)
- Advertising (3)
- Listed medicines (3)
- Non-prescription medicines (3)
- Fees and payments (2)
- Sunscreens (2)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Clinical trials (1)
- Import and export (1)
- In Vitro Diagnostic medical devices (IVDs) (1)
- Medical devices safety (1)
- Medicinal cannabis hub (1)
- Medicines safety (1)
- Nicotine vaping products hub (1)
- Other therapeutic goods (1)
- Safety (1)
- Unique Device Identification (UDI) Hub (1)
More on consultations
Find more scheduling consultations on the Poisons Standard in our Interim decisions.
Read the details of recent consultations, submissions and decisions at the TGA Consultation hub.
Trove at the National Library of Australia has information on archived TGA consultations and reviews.
Search
212 result(s) found, displaying 126 to 150
- Closed onConsultationConsultation: Regulatory options for appropriate access and safety controls for alkyl nitritesDiscussion paper outlining different approaches to access and safety controls for alkyl nitrites
- Closed onConsultationConsultation: Proposal for the regulation of IVD companion diagnosticsClosing date extended to 14 December 2018
- Closed onConsultationConsultation: Referral of proposed amendment to the current Poisons Standard to the meeting of the ACMS, March 2019Advisory Committee on Medicines Scheduling to consider upscheduling of modified release paracetamol to 'Pharmacist Only'. Closing date 31 October 2018
- Closed onConsultationConsultation: Referral of proposed amendments to the current Poisons Standard to the ACMS, Joint ACCS-ACMS or ACCS meeting, November 2018Invitation to comment on proposed Poisons Standard amendments. Closing date: 28 September 2018
- Closed onConsultationIMDRF consultation: Terminologies for categorised adverse event reportingThe IMDRF sought comments on a proposed document and its annexes
- Closed onConsultationIMDRF consultation: Unique Device Identification systemThe IMDRF sought comments on a proposed guidance document and two information documents
- Closed onConsultationConsultation: Boxed Warning guidanceThe TGA is seeking comments on the proposed guidance for the use of Boxed Warnings for prescription medicines. Closing date: 31 August 2018
- Closed onConsultationIMDRF consultation: Principles of labelling for medical devices and IVD medical devicesThe IMDRF is seeking comments on a proposed guidance document
- Closed onConsultationConsultation: Proposed Schedule 3 substances to be added to Appendix H of the Poisons StandardThe TGA sought comments on the proposed Schedule 3 substances to be added to Appendix H of the Poisons Standard to allow them to be advertised direct to consumers. Closing date 9 July 2018
- Closed onConsultationConsultation: Proposed amendments to the Poisons Standard being referred to the June 2018 meetings of the ACCS, ACMS and Joint ACCS/ACMSCarbendazim has been deferred from the June 2018 ACCS meeting at the applicant’s request.
- Closed onConsultationConsultation: Prescription strong (Schedule 8) opioid use and misuse in Australia – options for a regulatory responseConsultation on options for a regulatory response to the potential misuse of prescribed Schedule 8 opioids in Australia
- Closed onConsultationConsultation: Proposed regulatory changes related to personalised and 3D printed medical devicesConsultation on future options for the regulation of personalised and 3D printed medical devices. Closing date: 22 December 2017
- Closed onConsultationConsultation: Proposed Amendments to the Poisons Standard - ACCS, ACMS and Joint ACCS-ACMS meetings, March 2018Invitation to comment on proposed amendments to the Poisons Standard. Closing date: 2 February 2018
- Closed onConsultationConsultation: Discontinuing pre-market evaluation of Herbal Component Names (HCNs)Consultation on proposed process for pre-market evaluation of HCNs. Closing date: 12 January 2018
- Closed onConsultationConsultation: Proposed amendments to the Poisons Standard - ACCS, ACMS and Joint ACCS/ACMS meetings, November 2017Invitation to comment on proposed amendments to the Poisons Standard - ACCS, ACMS & Joint ACCS/ACMS meetings, November 2017
- Closed onConsultationConsultation: Alignment with European medical device regulatory frameworkConsultation on proposed changes to up-classify surgical mesh medical devices and to provide patient implant cards for implantable medical devices. Closing date: 25 August 2017
- Closed onConsultationConsultation: Proposed amendments to the Poisons Standard - Joint ACCS/ACMS meeting, July 2017The TGA sought comments from interested parties on the proposed amendments to the Poisons Standard. Closing date: 7 July 2017
- Closed onConsultationConsultation: Comparable overseas regulators - medical devicesConsultation on comparable overseas regulators. Closing date: 30 June 2017
- Closed onConsultationConsultation: Proposed Amendments to the Poisons Standard - ACCS, ACMS and Joint ACCS/ACMS meetings, July 2017The TGA sought comments from interested parties on the proposed amendments to the Poisons Standard. Closing date: 15 June 2017
- Closed onConsultationConsultation: The Scheduling Policy Framework and Advertising of Pharmacist-only medicines (Schedule 3 substances)Options for the reform of the SPF and advertising controls of Schedule 3 medicines. Closing date: 28 April 2017
- Closed onConsultationConsultation: Options for the future regulation of 'low risk' productsThe TGA sought comments from interested parties on the options for the future regulation of 'low risk' products. Closing date: 12 May 2017
- Closed onConsultationConsultation: Accelerated assessment of medical devices - Priority Review pathway - ImplementationConsultation on discussion paper. Closing date: 11 January 2017
- Closed onConsultationConsultation: Designation of Australian conformity assessment bodies for medical devices - ImplementationConsultation on discussion paper. Closing date: 11 January 2017
- Closed onConsultationConsultation: Software as a Medical Device (SaMD): Clinical EvaluationIMDRF consultation document. Closing date: 2 December 2016
- Closed onConsultationConsultation: Proposed Amendments to the Poisons Standard - ACCS and ACMS meetings, November 2016Consultation on the proposed amendments to the Poisons Standard. Closing date: 20 October 2016